Medline IPO Raises $6.3 Billion, Valuing Company at Over $50 Billion

Medline's IPO raises $6.3 billion, valuing the company at over $50 billion. The medical supply giant's stock rose 22% in early trading, marking the year's biggest IPO. Private equity giants Blackstone, Carlyle, and Hellman & Friedman took a majority stake in the company in 2021. The deal caps the best IPO year since 2021, with a positive outlook for 2026.